HEADER LIGASE 14-APR-00 1EUD TITLE CRYSTAL STRUCTURE OF PHOSPHORYLATED PIG HEART, GTP-SPECIFIC SUCCINYL- TITLE 2 COA SYNTHETASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUCCINYL-COA SYNTHETASE, ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SCS-ALPHA; COMPND 5 EC: 6.2.1.4; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SUCCINYL-COA SYNTHETASE, BETA CHAIN; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: SCS-BETA; COMPND 11 EC: 6.2.1.4; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 TISSUE: HEART; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-3B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 12 ORGANISM_COMMON: PIG; SOURCE 13 ORGANISM_TAXID: 9823; SOURCE 14 TISSUE: HEART; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET-3B KEYWDS LIGASE, GTP-SPECIFIC, PHOSPHONOHISTIDINE EXPDTA X-RAY DIFFRACTION AUTHOR M.E.FRASER,M.N.G.JAMES,W.A.BRIDGER,W.T.WOLODKO REVDAT 4 24-JUL-19 1EUD 1 REMARK LINK REVDAT 3 24-FEB-09 1EUD 1 VERSN REVDAT 2 01-APR-03 1EUD 1 JRNL REVDAT 1 27-JUL-00 1EUD 0 JRNL AUTH M.E.FRASER,M.N.JAMES,W.A.BRIDGER,W.T.WOLODKO JRNL TITL PHOSPHORYLATED AND DEPHOSPHORYLATED STRUCTURES OF PIG HEART, JRNL TITL 2 GTP-SPECIFIC SUCCINYL-COA SYNTHETASE. JRNL REF J.MOL.BIOL. V. 299 1325 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 10873456 JRNL DOI 10.1006/JMBI.2000.3807 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 39063 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3935 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 1.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EUD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-00. REMARK 100 THE DEPOSITION ID IS D_1000010900. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-95 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 4 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : WEIS REMARK 200 DATA SCALING SOFTWARE : WEIS, BIOMOL (KBRANI, KBAPLY) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39063 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 41.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM,POTASSIUM(1:3) PHOSPHATE, 2 REMARK 280 -MERCAPTOETHANOL, AMMONIUM SULFATE, MICRODIALYSIS, TEMPERATURE REMARK 280 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.13900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS AN ALPHA, BETA-DIMER CONSTRUCTED REMARK 300 OF CHAINS A AND B. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -4 REMARK 465 ALA A -3 REMARK 465 ILE A -2 REMARK 465 ARG A -1 REMARK 465 HIS A 0 REMARK 465 LYS B 395 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS B 268 CB CYS B 268 SG -0.099 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 138 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 47 112.86 -162.84 REMARK 500 PRO B 94 170.25 -55.40 REMARK 500 LEU B 262 -168.87 -125.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 396 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 397 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EUC RELATED DB: PDB REMARK 900 1EUC IS CRYSTAL STRUCTURE OF DEPHOSPHORYLATED PIG HEART, GTP- REMARK 900 SPECIFIC SUCCINYL-COA SYNTHETASE REMARK 900 RELATED ID: 2SCU RELATED DB: PDB REMARK 900 2SCU IS PHOSPHORYLATED SUCCINYL-COA SYNTHETASE FROM E. COLI REMARK 900 RELATED ID: 1CQI RELATED DB: PDB REMARK 900 1CQI IS CRYSTAL STRUCTURE OF THE COMPLEX OF ADP AND MG2+ WITH REMARK 900 DEPHOSPHORYLATED E. COLI SUCCINYL-COA SYNTHETASE REMARK 900 RELATED ID: 1CQJ RELATED DB: PDB REMARK 900 1CQJ IS CRYSTAL STRUCTURE OF DEPHOSPHORYLATED E. COLI SUCCINYL-COA REMARK 900 SYNTHETASE DBREF 1EUD A -2 306 GB 2258465 AAB94003 25 333 DBREF 1EUD B 1 395 UNP P53590 SUCB2_PIG 23 417 SEQADV 1EUD MET A -4 GB 2258465 CLONING ARTIFACT SEQADV 1EUD ALA A -3 GB 2258465 CLONING ARTIFACT SEQADV 1EUD NEP A 259 GB 2258465 HIS 286 MODIFIED RESIDUE SEQADV 1EUD MET B 0 UNP P53590 CLONING ARTIFACT SEQADV 1EUD VAL B 1 UNP P53590 LEU 23 ENGINEERED SEQADV 1EUD CME B 332 UNP P53590 CYS 354 MODIFIED RESIDUE SEQADV 1EUD CSS B 343 UNP P53590 CYS 365 MODIFIED RESIDUE SEQRES 1 A 311 MET ALA ILE ARG HIS CYS SER TYR THR ALA SER ARG LYS SEQRES 2 A 311 HIS LEU TYR VAL ASP LYS ASN THR LYS VAL ILE CYS GLN SEQRES 3 A 311 GLY PHE THR GLY LYS GLN GLY THR PHE HIS SER GLN GLN SEQRES 4 A 311 ALA LEU GLU TYR GLY THR ASN LEU VAL GLY GLY THR THR SEQRES 5 A 311 PRO GLY LYS GLY GLY LYS THR HIS LEU GLY LEU PRO VAL SEQRES 6 A 311 PHE ASN THR VAL LYS GLU ALA LYS GLU GLN THR GLY ALA SEQRES 7 A 311 THR ALA SER VAL ILE TYR VAL PRO PRO PRO PHE ALA ALA SEQRES 8 A 311 ALA ALA ILE ASN GLU ALA ILE ASP ALA GLU VAL PRO LEU SEQRES 9 A 311 VAL VAL CYS ILE THR GLU GLY ILE PRO GLN GLN ASP MET SEQRES 10 A 311 VAL ARG VAL LYS HIS ARG LEU LEU ARG GLN GLY LYS THR SEQRES 11 A 311 ARG LEU ILE GLY PRO ASN CYS PRO GLY VAL ILE ASN PRO SEQRES 12 A 311 GLY GLU CYS LYS ILE GLY ILE MET PRO GLY HIS ILE HIS SEQRES 13 A 311 LYS LYS GLY ARG ILE GLY ILE VAL SER ARG SER GLY THR SEQRES 14 A 311 LEU THR TYR GLU ALA VAL HIS GLN THR THR GLN VAL GLY SEQRES 15 A 311 LEU GLY GLN SER LEU CYS VAL GLY ILE GLY GLY ASP PRO SEQRES 16 A 311 PHE ASN GLY THR ASP PHE THR ASP CYS LEU GLU ILE PHE SEQRES 17 A 311 LEU ASN ASP PRO ALA THR GLU GLY ILE ILE LEU ILE GLY SEQRES 18 A 311 GLU ILE GLY GLY ASN ALA GLU GLU ASN ALA ALA GLU PHE SEQRES 19 A 311 LEU LYS GLN HIS ASN SER GLY PRO LYS SER LYS PRO VAL SEQRES 20 A 311 VAL SER PHE ILE ALA GLY LEU THR ALA PRO PRO GLY ARG SEQRES 21 A 311 ARG MET GLY NEP ALA GLY ALA ILE ILE ALA GLY GLY LYS SEQRES 22 A 311 GLY GLY ALA LYS GLU LYS ILE THR ALA LEU GLN SER ALA SEQRES 23 A 311 GLY VAL VAL VAL SER MET SER PRO ALA GLN LEU GLY THR SEQRES 24 A 311 THR ILE TYR LYS GLU PHE GLU LYS ARG LYS MET LEU SEQRES 1 B 396 MET VAL ASN LEU GLN GLU TYR GLN SER LYS LYS LEU MET SEQRES 2 B 396 SER ASP ASN GLY VAL LYS VAL GLN ARG PHE PHE VAL ALA SEQRES 3 B 396 ASP THR ALA ASN GLU ALA LEU GLU ALA ALA LYS ARG LEU SEQRES 4 B 396 ASN ALA LYS GLU ILE VAL LEU LYS ALA GLN ILE LEU ALA SEQRES 5 B 396 GLY GLY ARG GLY LYS GLY VAL PHE SER SER GLY LEU LYS SEQRES 6 B 396 GLY GLY VAL HIS LEU THR LYS ASP PRO GLU VAL VAL GLY SEQRES 7 B 396 GLN LEU ALA LYS GLN MET ILE GLY TYR ASN LEU ALA THR SEQRES 8 B 396 LYS GLN THR PRO LYS GLU GLY VAL LYS VAL ASN LYS VAL SEQRES 9 B 396 MET VAL ALA GLU ALA LEU ASP ILE SER ARG GLU THR TYR SEQRES 10 B 396 LEU ALA ILE LEU MET ASP ARG SER CYS ASN GLY PRO VAL SEQRES 11 B 396 LEU VAL GLY SER PRO GLN GLY GLY VAL ASP ILE GLU GLU SEQRES 12 B 396 VAL ALA ALA SER ASN PRO GLU LEU ILE PHE LYS GLU GLN SEQRES 13 B 396 ILE ASP ILE ILE GLU GLY ILE LYS ASP SER GLN ALA GLN SEQRES 14 B 396 ARG MET ALA GLU ASN LEU GLY PHE LEU GLY PRO LEU GLN SEQRES 15 B 396 ASN GLN ALA ALA ASP GLN ILE LYS LYS LEU TYR ASN LEU SEQRES 16 B 396 PHE LEU LYS ILE ASP ALA THR GLN VAL GLU VAL ASN PRO SEQRES 17 B 396 PHE GLY GLU THR PRO GLU GLY GLN VAL VAL CYS PHE ASP SEQRES 18 B 396 ALA LYS ILE ASN PHE ASP ASP ASN ALA GLU PHE ARG GLN SEQRES 19 B 396 LYS ASP ILE PHE ALA MET ASP ASP LYS SER GLU ASN GLU SEQRES 20 B 396 PRO ILE GLU ASN GLU ALA ALA LYS TYR ASP LEU LYS TYR SEQRES 21 B 396 ILE GLY LEU ASP GLY ASN ILE ALA CYS PHE VAL ASN GLY SEQRES 22 B 396 ALA GLY LEU ALA MET ALA THR CYS ASP ILE ILE PHE LEU SEQRES 23 B 396 ASN GLY GLY LYS PRO ALA ASN PHE LEU ASP LEU GLY GLY SEQRES 24 B 396 GLY VAL LYS GLU SER GLN VAL TYR GLN ALA PHE LYS LEU SEQRES 25 B 396 LEU THR ALA ASP PRO LYS VAL GLU ALA ILE LEU VAL ASN SEQRES 26 B 396 ILE PHE GLY GLY ILE VAL ASN CME ALA ILE ILE ALA ASN SEQRES 27 B 396 GLY ILE THR LYS ALA CSS ARG GLU LEU GLU LEU LYS VAL SEQRES 28 B 396 PRO LEU VAL VAL ARG LEU GLU GLY THR ASN VAL HIS GLU SEQRES 29 B 396 ALA GLN ASN ILE LEU THR ASN SER GLY LEU PRO ILE THR SEQRES 30 B 396 SER ALA VAL ASP LEU GLU ASP ALA ALA LYS LYS ALA VAL SEQRES 31 B 396 ALA SER VAL THR LYS LYS MODRES 1EUD NEP A 259 HIS N1-PHOSPHONOHISTIDINE MODRES 1EUD CME B 332 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 1EUD CSS B 343 CYS S-MERCAPTOCYSTEINE HET NEP A 259 14 HET CME B 332 10 HET CSS B 343 7 HET SO4 B 396 5 HET SO4 B 397 5 HETNAM NEP N1-PHOSPHONOHISTIDINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM CSS S-MERCAPTOCYSTEINE HETNAM SO4 SULFATE ION FORMUL 1 NEP C6 H10 N3 O5 P FORMUL 2 CME C5 H11 N O3 S2 FORMUL 2 CSS C3 H7 N O2 S2 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *188(H2 O) HELIX 1 1 SER A 2 TYR A 11 5 10 HELIX 2 2 GLY A 25 GLY A 39 1 15 HELIX 3 3 THR A 63 GLY A 72 1 10 HELIX 4 4 PRO A 81 ALA A 95 1 15 HELIX 5 5 PRO A 108 LEU A 120 1 13 HELIX 6 6 PRO A 147 HIS A 151 5 5 HELIX 7 7 GLY A 163 VAL A 176 1 14 HELIX 8 8 ASP A 195 ASP A 206 1 12 HELIX 9 9 ASN A 221 ASN A 234 1 14 HELIX 10 10 GLY A 270 ALA A 281 1 12 HELIX 11 11 SER A 288 ALA A 290 5 3 HELIX 12 12 GLN A 291 ARG A 303 1 13 HELIX 13 13 GLN B 4 ASP B 14 1 11 HELIX 14 14 THR B 27 ASN B 39 1 13 HELIX 15 15 GLY B 53 GLY B 57 5 5 HELIX 16 16 ASP B 72 GLN B 82 1 11 HELIX 17 17 ARG B 123 ASN B 126 5 4 HELIX 18 18 ASP B 139 ASN B 147 1 9 HELIX 19 19 PRO B 148 ILE B 151 5 4 HELIX 20 20 LYS B 163 LEU B 174 1 12 HELIX 21 21 LEU B 177 ILE B 198 1 22 HELIX 22 22 ASP B 227 ARG B 232 5 6 HELIX 23 23 GLN B 233 MET B 239 1 7 HELIX 24 24 GLU B 246 TYR B 255 1 10 HELIX 25 25 GLY B 272 ASN B 286 1 15 HELIX 26 26 LYS B 301 THR B 313 1 13 HELIX 27 27 ALA B 333 ALA B 342 1 10 HELIX 28 28 ASN B 360 ASN B 370 1 11 HELIX 29 29 ASP B 380 SER B 391 1 12 SHEET 1 A 7 THR A 54 HIS A 55 0 SHEET 2 A 7 LEU A 58 PHE A 61 -1 O LEU A 58 N HIS A 55 SHEET 3 A 7 ASN A 41 THR A 46 1 O GLY A 45 N PHE A 61 SHEET 4 A 7 LYS A 17 GLN A 21 1 N VAL A 18 O ASN A 41 SHEET 5 A 7 ALA A 75 ILE A 78 1 O ALA A 75 N ILE A 19 SHEET 6 A 7 LEU A 99 CYS A 102 1 O LEU A 99 N SER A 76 SHEET 7 A 7 ARG A 126 ILE A 128 1 O ARG A 126 N VAL A 100 SHEET 1 B 7 CYS A 141 GLY A 144 0 SHEET 2 B 7 GLY A 134 ASN A 137 -1 O VAL A 135 N ILE A 143 SHEET 3 B 7 GLN A 180 GLY A 185 -1 O CYS A 183 N ILE A 136 SHEET 4 B 7 LYS A 153 SER A 160 1 N GLY A 154 O GLN A 180 SHEET 5 B 7 GLY A 211 GLU A 217 1 O GLY A 211 N GLY A 157 SHEET 6 B 7 VAL A 242 ALA A 247 1 N VAL A 243 O ILE A 212 SHEET 7 B 7 VAL A 284 VAL A 285 1 N VAL A 284 O VAL A 242 SHEET 1 C 4 PHE B 22 ALA B 25 0 SHEET 2 C 4 VAL B 103 GLU B 107 -1 O VAL B 103 N ALA B 25 SHEET 3 C 4 ILE B 43 ALA B 47 -1 N VAL B 44 O ALA B 106 SHEET 4 C 4 VAL B 67 THR B 70 -1 O HIS B 68 N LEU B 45 SHEET 1 D 3 VAL B 58 PHE B 59 0 SHEET 2 D 3 ASN B 87 ALA B 89 -1 N ALA B 89 O VAL B 58 SHEET 3 D 3 VAL B 98 LYS B 99 -1 O VAL B 98 N LEU B 88 SHEET 1 E 5 PHE B 152 GLN B 155 0 SHEET 2 E 5 GLY B 127 SER B 133 -1 N LEU B 130 O GLU B 154 SHEET 3 E 5 ARG B 113 ASP B 122 -1 N TYR B 116 O SER B 133 SHEET 4 E 5 ALA B 200 THR B 211 -1 O THR B 201 N MET B 121 SHEET 5 E 5 GLN B 215 CYS B 218 -1 O GLN B 215 N THR B 211 SHEET 1 F 5 PHE B 152 GLN B 155 0 SHEET 2 F 5 GLY B 127 SER B 133 -1 N LEU B 130 O GLU B 154 SHEET 3 F 5 ARG B 113 ASP B 122 -1 N TYR B 116 O SER B 133 SHEET 4 F 5 ALA B 200 THR B 211 -1 O THR B 201 N MET B 121 SHEET 5 F 5 ALA B 221 PHE B 225 -1 O LYS B 222 N GLU B 204 SHEET 1 G 2 LYS B 258 GLY B 261 0 SHEET 2 G 2 ASN B 292 ASP B 295 -1 N PHE B 293 O ILE B 260 SHEET 1 H 4 ILE B 266 VAL B 270 0 SHEET 2 H 4 ALA B 320 PHE B 326 1 O ALA B 320 N ALA B 267 SHEET 3 H 4 LEU B 352 GLU B 357 1 N VAL B 353 O ILE B 321 SHEET 4 H 4 ILE B 375 SER B 377 1 O THR B 376 N VAL B 354 LINK C GLY A 258 N NEP A 259 1555 1555 1.33 LINK C NEP A 259 N ALA A 260 1555 1555 1.33 LINK C ASN B 331 N CME B 332 1555 1555 1.32 LINK C CME B 332 N ALA B 333 1555 1555 1.33 LINK C ALA B 342 N CSS B 343 1555 1555 1.32 LINK C CSS B 343 N ARG B 344 1555 1555 1.33 CISPEP 1 GLY A 129 PRO A 130 0 0.90 CISPEP 2 GLY A 236 PRO A 237 0 0.45 CISPEP 3 ASN B 206 PRO B 207 0 0.75 SITE 1 AC1 3 GLY B 52 GLY B 53 ARG B 54 SITE 1 AC2 5 GLY A 254 ARG A 255 ARG A 256 MET B 0 SITE 2 AC2 5 LYS B 258 CRYST1 86.907 82.278 50.017 90.00 104.37 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011507 0.000000 0.002948 0.00000 SCALE2 0.000000 0.012154 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020639 0.00000 MASTER 301 0 5 29 37 0 3 6 0 0 0 55 END